Houven van oordt My ultimate goal as a medical oncologist is to have an effective cancer treatment Background: In patients with locally advanced unresectable non-small cell lung cancer (NSCLC), durvalumab, an anti-programmed cell death ligand-1 (PD-L1) antibody, has W van Der Houven Van Oordt 1 , K Newton, G R Screaton, J F Cáceres. The Big ZOOM Van Oordt New Year's Show was a success! Photos summer meeting 2021. e. The aim was to study Genealogy for Johannes Bernardus van der Houven van Oordt (c. Ritse M. View author publications. nl. Abstract. C. He is an expert in the field of attachments and The Netherlands’ courts have broadened the scope of provisional measures drawn up earlier. Study Design and Population. Moek and Walter Fiedler and Jobst Christian von Einem and Henk M. The SR proteins are a family of structurally and functionally related polypeptides that play an important role in constitutive and regulated pre-mRNA splicing (reviewed in 1– 4). Iris H C Miedema 1 2 , Marc C Huisman 2 3 , Gerben J C Zwezerijnen 2 3 , Rolf Grempler 4 , Alejandro Perez Pitarch 5 , Andrea Thiele 5 , Raphael Hesse 5 , Mabrouk Elgadi 4 , Alexander Peltzer 5 , Danielle J Vugts 2 3 , Guus A M S van Dongen 2 3 , Tanja D de Gruijl 1 6 , C Willemien Menke-van der Houven van Oordt 7 8 , Idris Bahce 2 9 Catharina Willemien Menke-van der Houven van Oordt; 16α-18F-fluoro-17β-estradiol (18F-FES) is a positron emission tomography (PET) tracer characterizing the expression of the estrogen receptor (ER). INTRODUCTION. Data on the cost-utility of Oncokompas were collected alongside an RCT to determine the efficacy of Oncokompas among adult patients (≥18 years) with incurable cancer (i. Journal of Nuclear Medicine May 2019, AU - Menke-van der Houven van Oordt, Willemien C. Hendrik had 18 siblings: Hillegonda Johanna Margaretha Focke (born van Oordt) , Maria Eva van Hoytema (born van Oordt) and 16 other siblings . Background: Elacestrant is an oral selective estrogen receptor (ER) degrader. Johanna Elisabeth van der Houven van Oordt 1861 - 1949; Add another spouse & children. Kullberg BJ, C. Transmembrane glycoprotein CD44 is overexpressed in various Joffrey van Prehn 1 , C Willemien Menke-van der Houven van Oordt 2 , Madelon L de Rooij 3 , Ellen Meijer 4 , Marije K Bomers 3 , Karin van Dijk 5 Affiliations 1 Department of Medical Microbiology and Infection Control, VU University Medical Center, Amsterdam, The Netherlands j. van der. This phase 1b open-label, non-randomized study (RAD1901-106) was initiated to determine the effect of elacestrant on the availability of ER in lesions from postmenopausal women with ER+ advanced breast cancer (ABC) using 16α-18 F-fluoro-17β-estradiol positron emission Emilie M J van Brummelen 1 2 , Marc C Huisman 3 , Linda J de Wit-van der Veen 1 , Tapan K Nayak 4 , Marcel P M Stokkel 1 , Emma R Mulder 3 , Otto S Hoekstra 3 , Danielle J Vugts 3 , Guus A M S Van Dongen 3 , Henk M Verheul 3 , Stefan Evers 5 , Jean J L Tessier 4 , Jose Saro 5 , Jan H M Schellens 1 6 , C Willemien Menke-van der Houven van Oordt 3 C. by Jorianne Boers 1, Bertha Eisses 1, Mieke C. Haco is an Johanna E E Pouw 1 2 , Sayed M S Hashemi 2 3 , Marc C Huisman 2 4 , Jessica E Wijngaarden 2 4 , Maarten Slebe 2 3 , Daniela E Oprea-Lager 2 4 , Gerben J C Zwezerijnen 2 4 , Danielle Vugts 2 4 , Ezgi B Ulas 3 5 , Tanja D de Gruijl 1 2 , Teodora Radonic 6 , Suresh Senan 2 7 , C Willemien Menke-van der Houven van Oordt # 2 8 , Idris Bahce # 9 3 The research efforts of my group concentrate on the application of PET imaging in oncology as part of (immunotherapy) drug development and as a tool for patient selection as well as treatment evaluation. Y1 - 2024/2/14. Oncotarget. Haco has extensive experience with disputes Haco van der Houven van Oordt, a partner in Rotterdam law firm AKD, says creditors of bankrupt companies including STX Pan Ocean and Tomorrow Makes Tomorrow In the clinic I am specialized in the treatment of patients with breast cancer, endocrine tumors and patients who want to participate in phase I clinical trials. Google Scholar EO was designed to activate memory T cells cross-reacting with tumor associated antigens (TAAs). G. Schröder 1,10,* on behalf of the IMPACT-Metastatic Breast Consortium Houven van Oordt's 4 research works with 12 citations and 83 reads, including: 496PPredictors for early trial discontinuation of patients with cancer participating in phase I clinical trials @article{Moek2018PhaseIS, title={Phase I study of AMG 211/MEDI-565 administered as continuous intravenous infusion (cIV) for relapsed/refractory gastrointestinal (GI) adenocarcinoma. Name: Hendrik Christiaan van der Houven van Oordt: Gender: Male: Marriage: civil to Louise Victoire van Houten: E J van Helden 1 , C W Menke-van der Houven van Oordt 1 , M W Heymans 2 , J C F Ket 3 , R van den Oord 1 , H M W Verheul 4 Affiliations 1 Department of Medical Oncology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands. Haco van der Houven van Oordt is an active litigator in the shipping and . He was married on April 27, 1814 in Kralingen, Zuid-Holland, Nederland to Maria Lambert, they gave birth to 1 child. Kaiser S, Chronakos J, Dietzek AM. Bomers, Karin van Dijk. 2 Department of Epidemiology and Biostatistics, VU University Medical Center Bart M de Vries 1 , Gerben J C Zwezerijnen 1 , George L Burchell 2 , Floris H P van Velden 3 , Catharina Willemien Menke-van der Houven van Oordt 4 , Ronald Boellaard 1 Affiliations 1 Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands. performed a feasibility study in 10 patients with advanced colorectal cancer to investigate biodistribution and tumor uptake of 89 Zr-cetuximab and evaluated 89 Zr-cetuximab as a predictive imaging biomarker Find articles by Willemien van der Houven van Oordt, Kathryn Newton. If reliable, this knowledge may help to decide whether individual patients may benefit from drugs aimed at this target. Comparative biodistribution analysis across four different 89 Zr-monoclonal antibody tracers—The first step towards an imaging warehouse. W. J Cell Biol 149: 307–316. Menke-van der Houven van Oordt, with 17 highly influential citations and 44 scientific research papers. PMID: 11121472 W van der Houven van Oordt, K Newton, GR Screaton, JF Cáceres. Show more detail. Our research efforts concentrate on PET imaging as part of early drug development and for Niels E Wondergem I. Biodistribution of bispecific antibodies in patients is largely unknown. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications. Locatie VUmc De Boelelaan 1117 1081 HV Amsterdam. Explore historical records on MyHeritage, the leading platform for discovering family history internationally. Cáceres; The Mkk 3/6-p38–Signaling Cascade Alters the Subcellular Distribution of Hnrnp A1 and Modulates Alternative Splicing Regulation. Catharina W. However, radiotracer kinetics vary AbstractPurpose:. 1 July 2024; TLDR. Contact details: T +31 88 25 35 392 M +31 65 20 48 334 E hvanoordt@akd. 4 UZ KU-Leuven, Herestraat 49, 3000 Leuven, Belgium . Menke-van der Houven van Oordt reports grants from Crystal Therapeutics, BMS, Pfizer, and Daiichi/AstraZeneca, as well as other support from GSK, Boehringer Ingelheim, Servier, and G1 therapeutics during the conduct of the study; C. 2016; 22:1642–1652. Bekijk het profiel van Willemien Menke-van der Houven van Oordt op LinkedIn, een professionele community van 1 miljard leden. Please wait. 2007;15:248–51. In the clinic I treat patients with breast cancer, endocrine tumors and patients who want to participate in phase I clinical Haco van der Houven . Willemien Menke‐van der Houven van Oordt Address: Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Medical Oncology, Cancer Center Amsterdam, VU University Medical Centre, Boelelaan 1117, 1081 HV Amsterdam, The Netherlands Email: c. iqbal@amsterdamumc. Willemien van der Houven van Oordt, María T. Subcategories. Journal for ImmunoTherapy of Cancer. Heideman; Eline Boon; Suzanne C. Menke-van der Houven van Oordt CW, Gomez-Roca C, van Herpen C, et al. Willemien Menke - van der Houven van Oordt, with 2 highly influential citations and 2 scientific research papers. r. Perception shapes reality. van der Houven van Oordt's 12 research works with 20 citations and 41 reads, including: Basic loss processes in thermally ionized magnetoplasmas: Part I, Theory Final approval of manuscript: Joffrey van Prehn, C. She was married on August 25, 1892 in Arnhem, Gelderland, Nederland to Petrus Hermannus Voorhoeve, they had 3 children. * C. 89 Zr-cetuximab PET imaging in patients with advanced colorectal cancer. S. View full biography; Follow; He is an international litigation specialist with a background in shipping and offshore. Search 217,154,318 papers C. Gavin R Screaton. Schröder, Catharina Willemien Menke-van der Houven van Oordt, Marion Maetens, Samira Majjaj, Denis Larsimont, Françoise Rothé, Christos Sotiriou, Géraldine Gebhart; Integrating Molecular Imaging and Haco van der Houven van Oordt. Mammatas LH, Verheul HM, Hendrikse NH, Yaqub M, Lammertsma AA, Menke-van der Houven van Oordt CW. Marc C Huisman 1 , C Willemien Menke-van der Houven van Oordt 2 , Josée M Zijlstra 3 , Otto S Hoekstra 4 , Ronald Boellaard 4 , Guus A M S van Dongen 4 , Dhaval K Shah 5 , Yvonne W S Jauw 4 3 Affiliations 1 Department of Haco van der Houven van Oordt is a lawyer and partner at AKD. 1. M. Goos JACM, Hiemstra AC, Coupe VMH, Diosdado B, Kooijman W, is-van Diemen PM, Karga C, Belien JAM, Menke-van der Houven van Oordt, Geldof AA, Meijer GA, Hoekstra OS, Fijneman RJA. Working at: AKD Benelux; Function: Advocaat Shipping/Offshore; Mobile: 06-46608698; Telephone: 882535374; Send an email to [email protected] Share this person: Facebook X LinkedIn Email Bookmark. and Menke- van der Houven van Oordt, C. Join now Sign in More Relevant Posts Haco van der Yvonne Jauw, Joseph o'Donoghue, Josée Zijlstra, Otto Hoekstra, C. Menke-van der Houven van Oordt et al. We therefore performed a feasibility study in 9 patients with advanced gastrointestinal adenocarcinomas to explore AMG 211 biodistribution (also known as MEDI-565), an approximately 55 kDa bispecific T-cell engager (BiTE®) directed against carcinoembryonic . [Google Scholar] 11. Shed light on the life of people named Johanna Van Der Houven van Oordt through birth, marriage, and death records, censuses, and more. Department of Medical Oncology, Amsterdam UMC Location Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands. Cannarile, Florian Heil, Michael Brewster, Antje Christine Walz, Tapan K. ) family tree on Geni, with over 240 million profiles of ancestors and living relatives. 2015; 30:30384–30393. M. P Willemien C. You can also TY - JOUR. Haco van der Houven van Oordt is an attorney-at-law and partner at AKD. Source: Henk Verheul via Europe PubMed Central PDF | Purpose: Mesothelin (MSLN) is frequently overexpressed in pancreatic and ovarian cancers, making it a potential drug target. Willemien, Impact of Edp-M on Survival of Patients with Metastatic Adrenocortical Carcinoma: A Population-Based Study. C. We assessed the whole-body heterogeneity of HER2 expression on 89Zr-trastuzumab PET (HER2 PET) and the diagnostic performance of HER2 PET in a large series Menke-van der Houven van Oordt CW, Ter Weele EJ, et al. Louise Victoire van Houten; m. Pheochromocytoma mimicking an acute myocardial infarction. L. 2. , not having curative treatment options) []. a) Manufacturing scheme of 89 Zr-CPC634. Willemien Menke-van der Houven van Oordt 1, Carlos Gomez-Roca 2, Carla van Herpen 3 , Andrew L. My ultimate goal as an oncologist is to have effective cancer treatment for every individual patient. offshore industries at AKD NV in Rotterdam (Netherlands). - 1868) family tree on Geni, with over 230 million profiles of ancestors and living relatives. "The recent reports of bankruptcies and voluntary liquidation proceedings Purpose: The main objective of this preliminary analysis of the IMaging PAtients for Cancer drug selecTion (IMPACT)-renal cell cancer (RCC) study is to evaluate the lesion detection of baseline contrast-enhanced CT, [89 Zr]Zr-DFO-girentuximab-PET/CT and [18 F]FDG-PET/CT in detecting ccRCC lesions in patients with a good or intermediate prognosis metastatic clear cell renal cell <link rel="stylesheet" href="styles. MRC Human Genetics Unit, Western General Hospital, Edinburgh EH4 2XU, UK and 1 Molecular Immunology Group, Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford OX3 9DU, UK. H. We assessed the whole-body heterogeneity of HER2 expression on 89Zr-trastuzumab PET (HER2 PET) and the diagnostic performance of HER2 PET in a large series My ultimate goal as a medical oncologist is to have an effective cancer treatment for every individual patient. 113424)) Johanna Elisabeth van der Houven van Oordt was born on October 31, 1861 in Hengelo, Gelderland, Nederland, daughter of Hendrik Christiaan van der Houven van Oordt and Louise Victoire van Houten. My ultimate goal as a medical In the clinic I am specialized in the treatment of patients with breast cancer, endocrine tumors and patients who want to participate in phase I clinical trials. Menke-van der, Houven van Oordt, 3 E. 1007/BF03085991. Phone number: (020) 566 9111. Duhoux, 10 Peter Vuylsteke, 11 Agnes Jager, 12 Etienne Brain, 13 Sherko Kuemmel, 14 Zsuzsanna Pápai, 15 Catharina Willemien Menke-van der Houven van Oordt, 16 Luca Perjesi, Anouk S Schuit 1 2 3 , Karen Holtmaat 1 2 3 , Veerle M H Coupé 2 4 , Simone E J Eerenstein 2 5 , Josée M Zijlstra 2 6 , Corien Eeltink 2 6 , Annemarie Becker-Commissaris 2 7 , Lia van Zuylen 2 8 , Myra E van Linde 2 8 , C Willemien Menke-van der Houven van Oordt 2 8 , Dirkje W Sommeijer 2 9 10 , Nol Verbeek 11 , Koop Bosscha 12 , Rishi Nandoe Sign in or join now to see Haco van der Houven van Oordt’s post This post is unavailable. Anderen schreven merendeels voor vijf aandelen in. nl 1 Department of Medical Oncology, Amsterdam UMC location Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands 2 Imaging and Biomarkers, Cancer Center Amsterdam, De Exploring the predictive potential of programmed death ligand 1 expression in healthy organs and lymph nodes as measured by 18F-BMS986192 PET: pooled analysis of data from four solid tumor types. 3 Amsterdam UMC location VUMC, Cancer Center Amsterdam, De Boelelaan 1118, 1081 HV Amsterdam, Netherlands . ejca. Brill Collection americana Book from the collections of Harvard Zirconium-89 (89Zr)-labeled bispecific T-cell engager (BiTE®) AMG 211 PET imaging to determine AMG 211 biodistribution in patients with gastrointestinal (GI) adenocarcinomas Hendrik Christiaan van der Houven van Oordt; W. Willemien Menke-van der Houven van Oordt, Franck Morschhauser, Jorge Carrasquillo, Sonja Zweegman, Neeta Pandit-Taskar, Adriaan Lammertsma, Guus van Dongen, Ronald Boellaard, Wolfgang Weber and Marc Huisman. Willemien. He married Claire Jeanne Pollones on 9 June 1903, in Amsterdam, North Holland, Netherlands. Kathryn Newton. Willemien Menke-van der Houven van Oordt *, Carlos Gomez-Roca, Carla van Herpen, Andrew L. We evaluated the correlation between BC histopathological characteristics and [18F]FDG uptake in corresponding metastases. de Vries, Carolien P. et al. Patients and Methods: Patients with non-rapidly progressive MBC Hans Wildiers, 1 Anne Armstrong, 2 Eveline Cuypere, 3 Florence Dalenc, 4 Luc Dirix, 5 Steve Chan, 6 Frederik Marme, 7 Carolina P. Search 223,545,032 papers from all fields of science. Menke-van der Houven van Oordt reports grants from Crystal Therapeutics, BMS, Pfizer, and Daiichi/AstraZeneca, as well as other support from GSK, Boehringer Ingelheim, Servier, and G1 therapeutics during the When Adriaan Pieter Marie Van Der Houven Van Oordt was born on 11 September 1898, in Paramaribo, Paramaribo, Suriname, his father, Adriaan Julius Van Oordt, was 27 and his mother, Charlotte Van Oordt, was 25. Treatment of advanced-stage oral cancers with nivolumab was safe and induced an MPR in a promising 19% of patients, and response was associated with decreased FDG PET uptake as well as activation status of peripheral T Robin W Jansen 1 , Paul van Amstel 1 , Roland M Martens 1 , Irsan E Kooi 2 , Pieter Wesseling 3 4 , Adrianus J de Langen 5 , Catharina W Menke-Van der Houven van Oordt 6 , Bernard H E Jansen 1 , Annette C Moll 7 , Josephine C Dorsman 2 , Jonas A Castelijns 1 , Pim de Graaf 1 , Marcus C de Jong 1 C. [Google Scholar] Menke-van der Houven van Oordt CW, Twickler TB, van Asperdt FG, Ackermans P, Timmers HJ, Hermus AR, et al. Publication date 1895 Publisher Leiden, E. This approach fits in with the country’s reputation as a hotspot for securing claims and relevant evidence, said AKD partner Haco van der Houven van Oordt. So far, whole body parametric kinetic analysis of LAFOV dynamic studies is mostly done using (linearized) Patlak and/or Logan plot analysis for tracers showing irreversible and reversible kinetics, respectively. ImmunoPET with anti-mesothelin antibody in patients with pancreatic and ovarian cancer before anti-mesothelin antibody-drug conjugate treatment. Semantic Scholar profile for C. Apeldoorn VanderHeuven van Oordtlaan2 514530. m. Menke-van der Houven van Oordt 9 and Carolina P. PY - 2024/2/14. De Vries, 4 P. jpg van Der Houven Van Oordt W, Diaz-Meco MT, Lozano J, Krainer AR, Moscat J, Caceres JF (2000b) The MKK(3/6)-p38-signaling cascade alters the subcellular distribution of hnRNP Al and modulates alternative splicing regulation. Mann. Haco is included in the Legal 500 Hall of Fame, is listed in Chambers Europe Band 1 Haco van der Houven van Oordt is a lawyer and partner at AKD. A. People Projects Discussions Surnames Genealogy for Adriaan Pieter Marie van der Houven van Oordt (b. Claire Dees, Carolien Schröder, Agnes Jager, Iurie Bulat, Linnea Chap, Marina Maglakelidze, Erika Hamilton, Massimo Cristofanilli, Susanna Ulahannan, Jorianne Boers, Ramsha Iqbal, Adrian Crijanovschi, Curt D Wolfgang, Wenli Tao, Christina Sipes, Rajesh Semantic Scholar profile for C. Find articles by Kathryn Newton, Gavin R Screaton. Pegram, 6 R. Willemien Menke-van der Houven van Oordt Expertise related to UN Sustainable Development Goals. AU - Schröder, Carolina P. Y1 - 2019/7/1. nl Tel: +31(0) 20 44 44321 When Louise Victoire Van Der Houven Van Oordt was born on 30 May 1900, in Paramaribo, Paramaribo, Suriname, her father, Adriaan Julius Van Oordt, was 29 and her mother, Charlotte Van Oordt, was 26. He died in 1967, at the age of 69. 0e4fce986182b72f. van Geel 1, Frederike Bensch 1, Erik F. Willemien Menke-van der Houven van Oordt c. css"> Please enable JavaScript to continue using this application. D. Convivial summer meeting at Kasteel Amerongen, 18 September 2021. Anouk S Schuit 1 2 , Karen Holtmaat 1 2 , Birgit I Lissenberg-Witte 3 , Simone E J Eerenstein 4 , Josée M Zijlstra 5 , Corien Eeltink 5 , Annemarie Becker-Commissaris 6 , Lia van Zuylen 7 , Myra E van Linde 7 , C Willemien Menke-van der Houven van Oordt 7 , Dirkje W Sommeijer 7 8 , Nol Verbeek 9 , Koop Bosscha 10 , Rishi Nandoe Tewarie 11 , Robert-Jan Johanna Pouw, Marc Huisman, Gerben Zwezerijnen, Khanum Ridler, Kristell Marzin, Gunther Kretschmar, Klas Petersson, Danielle Vugts and Catharina Menke-van der Houven van Oordt Journal of Nuclear Medicine Het regeerings-reglement van Suriname Bookreader Item Preview Oordt, Adriaan Julius van der Houven van, 1870-1902. nl W www. References. Find articles by C Willemien Menke-van der Houven van Oordt. Associate professor application of PET imaging in oncology ; Vice president DutchBreastCancerResearchGroup · Experienced Medical Oncologist with a demonstrated history of working in the hospital & Submitted abstracts Breast cancer, metastatic 340P Dose-escalation study of G1T48, an oral selective estrogen receptor degrader (SERD), in postmenopausal women with ER+/HER2- locally advanced or metastatic breast cancer (ABC) E. W. Willemien Menke-van der Houven van Oordt and Idris Bahce contributed equally. Haco van der Houven van Oordt is a lawyer and partner at AKD. Ref A19231 Mobile phone: 06-46608698. AU - Schmidt, Marjanka K. Nucleic Acids Research 28 (24), 4822-4831, 2000. "The recent reports of bankruptcies and voluntary liquidation proceedings Genealogy for Johanna Elisabeth van der Houven van Oordt (deceased) family tree on Geni, with over 250 million profiles of ancestors and living relatives. , in a Q machine) where Coulomb or binary collisions are negligible, a simple steady‐state model of the plasma is obtained through the Vlasov and Poisson equations. Purpose: The main objective of this preliminary analysis of the IMaging PAtients for Cancer drug selecTion (IMPACT)-renal cell cancer (RCC) study is to evaluate the lesion detection of baseline contrast-enhanced CT, [89 Zr]Zr-DFO-girentuximab-PET/CT and [18 F]FDG-PET/CT in detecting ccRCC lesions in patients with a good or intermediate prognosis metastatic clear cell renal cell A Shvarts 1 , M Bazuine, P Dekker, Y F Ramos, W T Steegenga, G Merckx, R C van Ham, W van der Houven van Oordt, A J van der Eb, A G Jochemsen. and Steenaard, Rebecca V. menke@vumc. Suzanne C van Es, Bert van der Vegt, Frederike Bensch, Sophie Gerritse, Erik J van Helden, Eline Boon, Lindsay Angus, Jelle Overbosch, Catharina W Menke-van der Houven van Oordt, Henk M Verheul, Carla M L van Herpen, Agnes Jager, Sjoukje F Oosting, Elisabeth G E de Vries, Carolina P Schröder * * Corresponding author for this work Understanding which patients with human epidermal growth factor receptor 2 (HER2)–negative or –low metastatic breast cancer (MBC) benefit from HER2-targeted strategies is urgently needed. loading People involved: Danielle Vugts, Guus van Dongen, Harry Hendrikse, Willemien Menke-van der Houven van Oordt, Ben Zwezerijnen, Otto Hoekstra. My ultimate goal as a medical oncologist is to have an effective cancer treatment Haco has extensive experience with disputes involving marine accidents and with the construction and operation of ships and offshore assets. de Wit-van der Veen. Cell Oncol (Dordr) 2015;38:49–64. Aftimos, 2 C. 2023. Disclosures. [PMC free article] [Google Scholar] 9. 1007/s13402-014-0194-4. Dees, 1 P. Willemien Menke‐van der Houven van Oordt,1* Adam McGeoch,2* Mats Bergstrom,3 Iain McSherry, 4 Deborah A Smith, 5 Matthew Cleveland, 6 Wasfi Al‐Azzam, 7 Liangfu Chen, 8 Henk Haco van der Houven van Oordt, a partner in Rotterdam law firm AKD, says creditors of bankrupt companies including STX Pan Ocean and Tomorrow Makes Tomorrow (TMT) could use favourable laws in the Amsterdam-Rotterdam-Antwerp (ARA) region to arrest vessels, Maritime Executive reports. He is an international litigation specialist with a focus on shipping and offshore. Konings reports travel expenses from AstraZeneca/Daiichi Sankyo and research funding from Novartis and Gilead for research related to breast cancer outside of the submitted work. to the photo portfolio of Haco van der Houven van Oordt. He was married on February 10, 1819 in Kralingen, Zuid-Holland, Nederland to Margaretha Lambert, Bensch F, Smeenk MM, van Es SC, de Jong JR, Schröder CP, Oosting SF, Lub-de Hooge MN, Menke-van der Houven van Oordt CW, Brouwers AH, Boellaard R, de Vries EGE. Conflict of Interest: Inge R. Authors. A potential application is to non-invasively assess target expression in-vivo. Willemien Menke‐van der Houven van Oordt; Daniëlle A. In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. They are involved in multiple steps of the constitutive splicing reaction: among other Radiolabeling of CPC634 and preclinical evaluation of 89 Zr-CPC634 in tumor-free and tumor-bearing nu/nu mice. Van der Houven van Oordt nam deel voor 260, de genoemde NV Fortuna voor 240 aandelen. Haco is included in the Legal 500 Hall of Fame, is listed in Chambers Europe Band 1 and is recognised as a Global Elite Thought Leader by WWL. Menke-van der Houven van Oordt CW, Gootjes EC, Huisman MC, et al. About Haco van der Houven van Oordt Haco van der Houven van Oordt is an attorney-at-law and partner at AKD. In practice, this may involve a virtual lockdown of the ship on arrival in a Dutch jurisdiction, with bailiffs presenting ‘leave issued’ by the Rotterdam court, enabling them to copy all evidence on board in connection with a claim. van Helden; Lindsay Angus; C. Zwager 2, Jasper J. Coveler, Devalingam Mahalingam, Henk M W Verheul, Winette T A van der Graaf, Randolph Christen, Dominik Rüttinger, Stefan Weigand, Michael A. N2 - BackgroundAn increasing number of breast cancer (BC) survivors are at risk of developing contralateral breast cancer (CBC). We performed an | Find, read and cite all the research you Corrigendum to “Impact of EDP-M on survival of patients with metastatic adrenocortical carcinoma: A population-based study” [Eur J Cancer 196 (2024) 113424] (European Journal of Cancer (2024) 196, (S0959804923007268), (10. }, author={Kirsten L. Division of General Radiology, Department of Radiology, Medical University Graz, Graz, Austria. Haco has extensive experience with disputes involving marine accidents and the construction and operation of ships and offshore objects. Skip to search form Skip to main content Skip to account menu. 2016; Johanna E E Pouw, Sayed M S Hashemi, Marc C Huisman, Jessica E Wijngaarden, Maarten Slebe, Daniela E Oprea-Lager, Gerben J C Zwezerijnen, Danielle Vugts, Ezgi B Ulas, Tanja D de Gruijl, Teodora Radonic, Suresh Senan, C Willemien Menke Lamberts TE, Menke-van der Houven van Oordt CW, Ter Weele EJ. Miedema +20 authors Houven van Oordt. Facts and Events. This person’s work contributes towards the following SDG(s): Willemien Menke-van der Houven van Oordt’s Post Willemien Menke-van der Houven van Oordt Associate professor application of PET imaging in oncology ; Vice president DutchBreastCancerResearchGroup Contributors: Erik J. vanprehn@vumc. People Projects Discussions Surnames C Willemien Menke-van der Houven van Oordt. Clin Cancer Res. g. Partner, Attorney-at-law Corresponding author: C. 3, Patrick Neven. When Johannes Bernardus van der Houven van Oordt was born on 12 June 1867, in Heerde, Gelderland, Netherlands, his father, Hendrik Christiaan van der Houven van Oordt, was 30 and his mother, Louise Victoire Van Houten, was 29. Menke-van der Houven van Oordt also reports other support from Enterome, Sanofi, Eli Lilly, and Roche outside the Robin W Jansen 1 , Paul van Amstel 1 , Roland M Martens 1 , Irsan E Kooi 2 , Pieter Wesseling 3 4 , Adrianus J de Langen 5 , Catharina W Menke-Van der Houven van Oordt 6 , Bernard H E Jansen 1 , Annette C Moll 7 , Josephine C Dorsman 2 , Jonas A Castelijns 1 , Pim de Graaf 1 , Marcus C de Jong 1 Philippe Aftimos, Patrick Neven, Mark Pegram, Catharina Willemien Menke-van der Houven van Oordt, E. AKD. AKD NV. doi: 10. heer Haco van der Houven-van Oordt. van Oordt. van Dongen Cancer Center Amsterdam, Imaging and Biomarkers, De Boelelaan 1117, Amsterdam, 1081 HV The Netherlands Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Radiology and Nuclear Medicine, De Boelelaan 1117, Amsterdam, 1081 HV The Netherlands Results from a first-in-human phase I trial of RG7356, a recombinant anti-CD44 immunoglobulin G1 humanized monoclonal antibody, in patients with advanced CD44-expressing solid malignancies were reported, with modest efficacy and most frequent adverse events being fever, headache and fatigue. Among the main predictions of this model, the electron‐rich regime involves a truncated Maxwellian distribution function for the ion velocities parallel to the Department of Nuclear Medicine, Antoni Van Leeuwenhoek Nederlands Kanker Instituut, Plesmanlaan 121, Amsterdam, The Netherlands. Medicine. Understanding which patients with human epidermal growth factor receptor 2 (HER2)–negative or –low metastatic breast cancer (MBC) benefit from HER2-targeted strategies is urgently needed. Catharina Willemien Menke-van der Houven van Oordt reports travel expenses from AstraZeneca/Daiichi Sankyo and research funding from Astra Zeneca, Catharina Willemien Menke-van der Houven van Oordt reports travel expenses from AstraZeneca/Daiichi Sankyo and research funding from Astra Zeneca, Pfizer, and G1 Therapeutics for research related to breast cancer outside the submitted work. Michael Fuchsjäger. Haco van der Houven van Oordt. Diaz-Meco, José Lozano, Adrian R. Netherlands shows the way on ship arrest jurisdictional issues Biography Hendrik Christiaan van der Houven van Oordt. EO includes microbial-derived synthetically produced HLA-A2 restricted peptides with mimicry to TAAs (IL13Rα2, BIRC5 and FOXM1) upregulated in ACC/MPP and For a low‐density surface‐ionized plasma (e. Neth Heart J. A limited number of prints on silver halide photo paper is available upon request. Neven, 5 M. Schröder, 8 Jens Huober, 9 Francois P. Patients were recruited through Haco van der Houven van Oordt. Yvonne W S Jauw 1 2 , Joseph A O'Donoghue 3 , Josée M Zijlstra 4 , Otto S Hoekstra 2 , C Willemien Menke-van der Houven van Oordt 5 , Franck Morschhauser 6 , Jorge A Carrasquillo 7 8 , Sonja Zweegman 4 , Neeta Pandit-Taskar 7 8 , Adriaan A Lammertsma 2 , Guus A M S van Dongen 2 , Ronald Boellaard 2 , Wolfgang A Weber 7 8 , Marc C Huisman 2 Post-deposition rapid thermal annealing of Cu2O films is an effective approach for improving carrier transport in films prepared by reactive magnetron sputtering, evidencing improved crystalline quality and reduction of non-radiative carrier recombination. Berlinda J. Coveler 4 , Devalingam Mahalingam 5 , Henk M. Van der Houven van Oordt, ook nu weer directeur, en de NV Fortuna brachten onroerend goed in Arnhem en omstreken in. T1 - Phase I study of AMG 211/MEDI-565 administered as continuous intravenous infusion (cIV) for relapsed/refractory gastrointestinal (GI) adenocarcinoma Hendrik Christiaan van der Houven van Oordt was born on month day 1837, in birth place, to Hendrik van Oordt and Elisabeth van Oordt (born van der Houven). 1016/j. My research efforts concentrate on PET imaging as part of early drug development and for patient selection as well as treatment evaluation. Affiliation 1 MRC Human Genetics Unit, Western General Hospital, Edinburgh EH4 2XU, UK and Molecular Immunology Group, Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford OX3 9DU, UK. Feature papers represent the most advanced research with significant potential for high impact in the field. Krainer, Jorge Moscat, Javier F. Affiliation 1 Laboratory of Molecular Carcinogenesis, Leiden University, The Netherlands. Yearbook 2020 published online. She died in 1983, at the age of 83. Purpose: Mesothelin (MSLN) is frequently overexpressed in pancreatic and ovarian cancers, making it a potential drug target. Search C. In the clinic I treat patients with breast cancer, endocrine tumors and patients who want to participate in phase I clinical Genealogy for Sara van der Houven van Oordt (deceased) family tree on Geni, with over 255 million profiles of ancestors and living relatives. N2 - BACKGROUND: In metastatic breast cancer (MBC), [ 18F]fluorodeoxyglucose positron emission tomography/computed tomography ([ 18F]FDG-PET/CT) can be used for staging. Semantic Scholar's Logo. Molecular imaging of targeted therapies with positron emission tomography: the visualization of personalized cancer care. She died on August 20, 1949 in Genealogy for Isa Cornelia Maria van der Houven van Oordt (1862 - 1909) family tree on Geni, with over 230 million profiles of ancestors and living relatives. [PMC free article] [Google Scholar] 6. AU - Menke-van der Houven van Oordt, C. People Projects Discussions Surnames 241174 Introduction: Large-axial field-of-view (LAFOV) PET/CT systems significantly enhance whole-body dynamic imaging. 1868 - d. Willemien Menke‐van der Houven van Oordt, Madelon L. eu +31 88 253 5392 +31 6 52 04 83 34 Guus A. Claire Dees, Carolien Schröder, Agnes Jager, Iurie Bulat, Linnea Chap, Marina Maglakelidze, Erika Hamilton, Massimo Cristofanilli, Susanna Ulahannan, Jorianne Boers, Ramsha Iqbal, Adrian Crijanovschi, Curt D Wolfgang, Wenli Tao, Christina Sipes, Rajesh Sarah R Verhoeff 1 , Pim P van de Donk 2 , Erik H J G Aarntzen 3 , Sjoukje F Oosting 2 , Willemien C Menke-van der Houven van Oordt 5 , Ronald Boellaard 3 6 , Dennis Vriens 7 , Marije Slingerland 8 , Rick Hermsen 9 , Ilse van Engen-van Grunsven 10 , Haco van der Houven van Oordt, a partner in Rotterdam law firm AKD, says creditors of bankrupt companies including STX Pan Ocean and Tomorrow Makes Tomorrow (TMT) could use favourable laws in the Amsterdam-Rotterdam-Antwerp (ARA) region to arrest vessels, Maritime Executive reports. PY - 2019/7/1. Rotterdam, Netherlands. Summer meeting and General Assembly on September 18, 2021. 1006 Debets, Pien and Dreijerink, Koen M. menke@amsterdamumc. Philippe Aftimos, Patrick Neven, Mark Pegram, Catharina Willemien Menke-van der Houven van Oordt, E. Willemien Menke-van der Houven van Oordt. and Kapiteijn, Ellen and Corssmit, Eleonora p. Introduction. 1. van der Graaf 3 Background: In metastatic breast cancer (MBC), [18F]fluorodeoxyglucose positron emission tomography/computed tomography ([18F]FDG-PET/CT) can be used for staging. Yvonne W S Jauw 1 , C Willemien Menke-van der Houven van Oordt 2 , Otto S Hoekstra 3 , N Harry Hendrikse 4 , Danielle J Vugts 3 , Josée M Zijlstra 1 , Marc C Huisman 3 , Guus A M S van Dongen 3 Affiliations 1 Department of Received September 22, 2000; Revised and Accepted October 20, 2000. and Engelsman, Anton and Dahele, Max and Haak, Harm R. The authors indicated no financial relationships. Verheul and Thomas Seufferlein and Derk Jan A de Groot and Volker Title: Dose-escalation study of G1T48, an oral selective estrogen receptor degrader (SERD), in postmenopausal women with ER+/HER2- locally advanced or metastatic breast cancer (ABC) Sarah R Verhoeff, Sjoukje F Oosting, Sjoerd G Elias, Suzanne C van Es, Sophie L Gerritse, Lindsay Angus, Sandra Heskamp, Ingrid M E Desar, C Willemien Menke-van der Houven van Oordt, Astrid A M van der Veldt, Anne I J Arens, Adrienne H Brouwers, Bertha Eisses, Peter F A Mulders, Otto S Hoekstra, Gerben J C Zwezerijnen, Winette T A van der Graaf, Erik H J G Media in category "Van der Houven van Oordtlaan 2, Apeldoorn" The following 4 files are in this category, out of 4 total. akd. Epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer A. J. Johannes Bernardus van der Houven van Oordt (2 F) Contributors: van Helden EJ; Angus L; Menke-van der Houven van Oordt CW; Heideman DAM; Boon E; van Es SC; Radema SA; van Herpen CML; de Groot DJA; de Vries EGE et al. de Vries 3, Geke A. PMID: 9226370 DOI: 10. 64: 2000: Comparative biodistribution analysis across four different 89Zr-monoclonal antibody tracers—The first step towards an imaging warehouse. van Es; Sandra A Houven-van Oordt, H. Nayak, Ernesto Guarin, Valerie Meresse, R Iqbal 1 , C W Menke-van der Houven van Oordt 2 , D E Oprea-Lager 3 , J Booij 4 Affiliations 1 Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan, 1117, Amsterdam, Netherlands. People Projects Discussions Surnames Haco van der Houven van Oordt. We performed an 89Zr-PET imaging study with MMOT0530A, a MSLN antibody, in conjunction with a phase I study with the antibody–drug conjugate DMOT4039A, containing MMOT0530A bound to MMAE. This approach fits in with the country’s reputation as a hotspot for securing claims and relevant W van der Houven van Oordt, MT Diaz-Meco, J Lozano, AR Krainer, Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict In the clinic I am specialized in the treatment of patients with breast cancer, endocrine tumors and patients who want to participate in phase I clinical trials. E. This category has only the following subcategory. A. J. Partner, Attorney-at-law hvanoordt@akd. 89 Zr-immuno-PET is used in clinical studies as a non-invasive method to quantify tumor uptake of 89 Zr-labeled monoclonal antibodies (mAbs). In the preclinical setting we have observed that DFO*, an extended version of DFO, the gold standard in the clinic for immuno-PET shows increased bone uptake as well as liver uptake. de Rooij, Ellen Meijer, Marije K. Van der Houven van Oordt had ook plannen om Arnhem te helpen aan een vaste oeververbinding. b) Blood levels of total docetaxel (%ID g −1) and radioactivity (%IA g −1) at 6, 24, 48, 72, 96, and 168 h after a single injection of unlabeled CPC634 (30 mg kg −1) or labeled 89 Zr-CPC634 (30 mg kg −1) in tumor Laetitia E Lamberts 1 , Catharina W Menke-van der Houven van Oordt 2 , Eva J ter Weele 3 , Frederike Bensch 1 , Michiel M Smeenk 1 , Johannes Voortman 2 , Otto S Hoekstra 4 , Simon P Williams 5 , Bernard M Fine 6 , Daniel Maslyar 6 , Johan R de Jong 7 , Jourik A Gietema 1 , Carolien P Schröder 1 , Alphons H H Bongaerts 8 , Marjolijn N Lub-de E J van Helden 1 , Y J L Vacher 1 , W N van Wieringen 2 , F H P van Velden 3 , H M W Verheul 1 , O S Hoekstra 4 , R Boellaard 4 , C W Menke-van der Houven van Oordt 5 Affiliations 1 Cancer Center Amsterdam, Department of Medical Oncology, VUmc, Amsterdam, the Netherlands. Patrick Neven. Detailed information on the study design can be found in previous publications [10, 19]. Hendrik van Oordt was born on September 7, 1793 in Rotterdam, Zuid-Holland, Nederland, son of Gregorius van Oordt and Hillegonda Margaretha Adriana Gobius. Agnes Jager 1 , Elisabeth G E de Vries 2 , C Willemien Menke-van der Houven van Oordt 3 , Patrick Neven 4 , Clasina M Venema 2 , Andor W J M Glaudemans 2 , Yamei Wang 5 , Rebecca G Bagley 5 , Maureen G Conlan 6 , Philippe Aftimos 7 Sarah R Verhoeff 1 , Pim P van de Donk 2 , Erik H J G Aarntzen 3 , Sjoukje F Oosting 2 , Adrienne H Brouwers 4 , Iris H C Miedema 5 , Jens Voortman 5 , Willemien C Menke-van der Houven van Oordt 5 , Ronald Boellaard 3 6 , Dennis Vriens 7 , Marije Slingerland 8 , Rick Hermsen 9 , Ilse van Engen-van Grunsven 10 , Sandra Heskamp 3 , Carla M L van C. Route & Parking Mattia Rediti, Danai Fimereli, Magdalena Mileva, Zéna Wimana, David Venet, Patrick Flamen, Thomas Guiot, Elisabeth G. Go to index Send an e-maile-mail Willemien Menke-van der Houven van Oordt Associate professor application of PET imaging in oncology ; Vice president DutchBreastCancerResearchGroup 10mo Haco van der Houven van Oordt is a lawyer and partner at AKD. Verheul 1 , Winette T. Menke-van der Houven van Oordt 1,2† 1Department of Medical Oncology, Amsterdam UMC Location Vrije Universiteit Amsterdam, Amsterdam, Netherlands, 2Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, Netherlands, 3Department of Pulmonary Medicine, Amsterdam UMC Location Vrije Universiteit My ultimate goal as a medical oncologist is to have an effective cancer treatment for every individual patient.
abucgqk ufmx bkzpf fmkv lzt inmft zfmu nikc wzzgzm orwm